Member Exclusive

Placing the Cell and Gene Therapy Catapult at the forefront of translational research: an interview with Jonathan Appleby

​In this interview, Jonathan Appleby discusses his appointment as the new Chief Scientific Officer of the Cell and Gene Therapy Catapult.

Go to the profile of Freya Leask
Jun 18, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.



Go to the profile of Sven Kili
Sven Kili 4 months ago

Well done Jonathan! What a great next move for someone so well deserving.